
Top news of the week on Specialty Pharmacy Times.
Manufacturer coupons found to show significant benefits reducing Sovaldi cost share.
HIV screenings at home and immediate administration of antiretroviral therapy in HIV-positive patients shows promise.
Top news of the day from across the health care landscape.
Pediatric Hodgkin lymphoma survivors are twice as likely to develop cardiovascular disease.
It was previously believed that HIV-related brain inflammation may prevent Alzheimer’s disease.
Study offers hope to women for whom infertility treatments were unsuccessful.
ASCL1 protein critical in the development of small cell lung cancer.
A look at the lighter side of pharmacy and the rigors of patient management.
An ideal patient care model in specialty pharmacy involves several factors.
Vyndaqel in development for mild transthyretin familial amyloid polyneuropathy (TTR-FAP).
Olanzapine found to reduce chemotherapy-induced nausea and vomiting in cancer patients.
Glunomab may inhibit the progression of motor disorders associated with multiple sclerosis.
Treatment with Truvada highly effective in reducing the risk of HIV.
Top news of the day from across the health care landscape.
Certain mutations influence risk of drug resistance across several cancer types.
Zepatier is a fixed-dose combination therapy of elbasvir and grazoprevir for chronic hepatitis C.
Opdivo monotherapy for first-line lung cancer unable to meet primary endpoint of progression-free survival.
Keytruda is a humanized monoclonal antibody that increases the ability of the immune system to help detect and fight tumor cells.
Experimental drug showed strong efficacy in numerous cellular animal models of amyotrophic lateral sclerosis (ALS).
Ovarian cancer among the highest death rates for all gynecological cancers.
Top news of the day from across the health care landscape.
Damage associated with leukemia occurs in regions where DNA is transcribed actively.
Mark Tesell, PharmD, BCPS, clinical consultant pharmacist at UMass Medical School Clinical Pharmacy Services, discusses the components of successful medication therapy management.
The importance of a clear line of communication between specialty pharmacies and prescribers.
The relevancy of randomized controlled trials of experimental drugs for multiple sclerosis in standard practice called into question.
Drugs that target the signal-peptide peptidase enzyme may halt HCV development.
Chimeric antigen receptors, typically studied for cancer immunotherapy, may treat HIV.
The new technology can separate bioparticles for improved cancer detection.
Study highlights the importance of sunscreen and other protective measures against skin cancer.